scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-5728(98)00135-0 |
P698 | PubMed publication ID | 9817444 |
P50 | author | Jorma A Määttä | Q42735748 |
P2093 | author name string | Salmi AA | |
Hinkkanen AE | |||
Nygårdas PT | |||
Sjöholm UR | |||
P2860 | cites work | Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta | Q21999071 |
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Cloning of a new cytokine that induces IFN-gamma production by T cells | Q28283928 | ||
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties | Q33576592 | ||
Modulation of CD4 antigen on macrophages and microglia in rat brain | Q34659073 | ||
Acquisition of lymphokine-producing phenotype by CD4+ T cells | Q34724514 | ||
Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains | Q36360977 | ||
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers | Q36361001 | ||
Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties | Q36445746 | ||
Mouse macrophage derived monocyte chemotactic protein-3: cDNA cloning and identification as MARC/FIC. | Q36731182 | ||
Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. | Q37363100 | ||
Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts | Q37562030 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
The ISCOM: an immunostimulating complex | Q41333996 | ||
Delineation of tissue damage mechanisms in experimental autoimmune encephalomyelitis (EAE). I. Cell detachment and lysis induced by encephalitogenic CD4+ T lymphocytes | Q41611202 | ||
Differential expression of mRNA encoding interleukin-12 p35 and p40 subunits in situ | Q42491827 | ||
Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis | Q45765166 | ||
Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis | Q45765768 | ||
Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system | Q45784536 | ||
Macrophages regulate induction of delayed‐type hypersensitivity and experimental allergic encephalomyelitis in SJL mice | Q46049242 | ||
Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice | Q48195865 | ||
Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse | Q48342316 | ||
Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse | Q48349566 | ||
Inducible expression of H-2 and Ia antigens on brain cells | Q48633246 | ||
Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse | Q49050942 | ||
Preferential Migration of Activated CD4 + and CD8 + T Cells in Response to MIP-1α and MIP-1β | Q52062623 | ||
Interferon-gamma confers resistance to experimental allergic encephalomyelitis. | Q52520772 | ||
Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. | Q54173280 | ||
Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice | Q57704270 | ||
Chemokine expression in murine experimental allergic encephalomyelitis | Q58201535 | ||
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs | Q59059475 | ||
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, | Q67543574 | ||
Phagocytosis of Opsonized Yeast Induces Tumor Necrosis Factor-α mRNA Accumulation and Protein Release by Human Polymorphonuclear Leukocytes | Q67921407 | ||
Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation | Q68382327 | ||
Host genetic regulation of acute MHV-4 viral encephalomyelitis and acute experimental autoimmune encephalomyelitis in (BALB/cKe x SJL/J) recombinant-inbred mice | Q69381189 | ||
Characterization of mouse macrophage differentiation antigens by monoclonal antibodies | Q69549031 | ||
Interferon-gamma is required during the initiation of an organ-specific autoimmune disease | Q71425966 | ||
Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β | Q71825997 | ||
Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells | Q71849926 | ||
Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization | Q73480802 | ||
P433 | issue | 2 | |
P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
P304 | page(s) | 162-175 | |
P577 | publication date | 1998-10-01 | |
P1433 | published in | Journal of Neuroimmunology | Q15716691 |
P1476 | title | Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis | |
P478 | volume | 90 |
Q49103717 | A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice |
Q35088195 | A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. |
Q45042000 | Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. |
Q41360196 | CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis |
Q48215354 | Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. |
Q35747177 | Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice |
Q82455889 | Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice |
Q37833524 | Histochemistry and cell biology: the annual review 2010. |
Q34660955 | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. |
Q40760409 | IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis |
Q34344447 | Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis |
Q26858882 | Innate immunity in the central nervous system |
Q30483471 | Models of autoimmune demyelination in the central nervous system: on the way to translational medicine |
Q48173043 | Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade |
Q34296297 | Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis |
Q35861951 | Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype |
Q47674870 | Protection from EAE by IL-4Ralpha(-/-) macrophages depends upon T regulatory cell involvement |
Q27325503 | The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis |
Q40513621 | Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2. |
Q48618073 | Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis |